Cargando…

Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma

Detalles Bibliográficos
Autores principales: Andersen, Rikke, Donia, Marco, Borch, Troels Holz, Steensgaard, Eva Ellebæk, Iversen, Trine Zeeberg, Kongsted, Per, Andersen, Mads Hald, Straten , Per thor, Svane, Inge Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288376/
http://dx.doi.org/10.1186/2051-1426-2-S3-P1
_version_ 1782351958725623808
author Andersen, Rikke
Donia, Marco
Borch, Troels Holz
Steensgaard, Eva Ellebæk
Iversen, Trine Zeeberg
Kongsted, Per
Andersen, Mads Hald
Straten , Per thor
Svane, Inge Marie
author_facet Andersen, Rikke
Donia, Marco
Borch, Troels Holz
Steensgaard, Eva Ellebæk
Iversen, Trine Zeeberg
Kongsted, Per
Andersen, Mads Hald
Straten , Per thor
Svane, Inge Marie
author_sort Andersen, Rikke
collection PubMed
description
format Online
Article
Text
id pubmed-4288376
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42883762015-01-15 Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma Andersen, Rikke Donia, Marco Borch, Troels Holz Steensgaard, Eva Ellebæk Iversen, Trine Zeeberg Kongsted, Per Andersen, Mads Hald Straten , Per thor Svane, Inge Marie J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288376/ http://dx.doi.org/10.1186/2051-1426-2-S3-P1 Text en Copyright © 2014 Andersen et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Andersen, Rikke
Donia, Marco
Borch, Troels Holz
Steensgaard, Eva Ellebæk
Iversen, Trine Zeeberg
Kongsted, Per
Andersen, Mads Hald
Straten , Per thor
Svane, Inge Marie
Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
title Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
title_full Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
title_fullStr Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
title_full_unstemmed Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
title_short Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
title_sort adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose il-2 for metastatic melanoma
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288376/
http://dx.doi.org/10.1186/2051-1426-2-S3-P1
work_keys_str_mv AT andersenrikke adoptivecelltherapywithtumorinfiltratinglymphocytesandintermediatedoseil2formetastaticmelanoma
AT doniamarco adoptivecelltherapywithtumorinfiltratinglymphocytesandintermediatedoseil2formetastaticmelanoma
AT borchtroelsholz adoptivecelltherapywithtumorinfiltratinglymphocytesandintermediatedoseil2formetastaticmelanoma
AT steensgaardevaellebæk adoptivecelltherapywithtumorinfiltratinglymphocytesandintermediatedoseil2formetastaticmelanoma
AT iversentrinezeeberg adoptivecelltherapywithtumorinfiltratinglymphocytesandintermediatedoseil2formetastaticmelanoma
AT kongstedper adoptivecelltherapywithtumorinfiltratinglymphocytesandintermediatedoseil2formetastaticmelanoma
AT andersenmadshald adoptivecelltherapywithtumorinfiltratinglymphocytesandintermediatedoseil2formetastaticmelanoma
AT stratenperthor adoptivecelltherapywithtumorinfiltratinglymphocytesandintermediatedoseil2formetastaticmelanoma
AT svaneingemarie adoptivecelltherapywithtumorinfiltratinglymphocytesandintermediatedoseil2formetastaticmelanoma